1.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Glob...
by Abd-Allah, Foad
The Lancet (British edition), 2017, Vol.390 (10100), p.1211-1259
2.
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016:...
by Abate, Kalkidan Hassen
The Lancet (British edition), 2017, Vol.390 (10100), p.1260-1344
3.
Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease
by Wiegman, Coen H., PhD
Journal of allergy and clinical immunology, 2015, Vol.136 (3), p.769-780
4.
Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study
by Gershon, Andrea S, Dr
The Lancet (British edition), 2011, Vol.378 (9795), p.991-996
5.
Chronic obstructive pulmonary disease
by Decramer, Marc, Prof
The Lancet (British edition), 2012, Vol.379 (9823), p.1341-1351
6.
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
by Suissa, Samy
Thorax, 2012, Vol.67 (11), p.957-963
7.
The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease
by Steer, John
Thorax, 2012, Vol.67 (11), p.970-976
8.
Asthma in older adults
by Gibson, Peter G, Prof
The Lancet (British edition), 2010, Vol.376 (9743), p.803-813
9.
Determinants and outcomes of physical activity in patients with COPD: a systematic review
by Gimeno-Santos, Elena
Thorax, 2014, Vol.69 (8), p.731-9
10.
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes
by Garcia-Aymerich, Judith
Thorax, 2011, Vol.66 (5), p.430-437
11.
The burden of disease in older people and implications for health policy and practice
by Prince, Martin J, Prof
The Lancet (British edition), 2015, Vol.385 (9967), p.549-562
12.
Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
by Bauer, Ursula E, PhD
The Lancet (British edition), 2014, Vol.384 (9937), p.45-52
13.
Chronic obstructive pulmonary disease
by Rabe, Klaus F, Prof
The Lancet (British edition), 2017, Vol.389 (10082), p.1931-1940
14.
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
by Romani, Luigina
Nature, 2008, Vol.451 (7175), p.211-215
15.
Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases
by Conti, Francesca, MD, PhD
Journal of allergy and clinical immunology, 2016, Vol.138 (1), p.241-248.e3
17.
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic anal...
by Degenhardt, Louisa
The Lancet (British edition), 2015, Vol.386 (9995), p.743-800
18.
Chronic inflammation in the etiology of disease across the life span
by Furman, David
Nature medicine, 2019, Vol.25 (12), p.1822-1832
19.
X-linked Carriers of Chronic Granulomatous Disease: Illness, Lyonization and Stability
by Marciano, Beatriz E., MD
Journal of allergy and clinical immunology, 2017
20.
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
by Barnes, Peter J., FRS, FMedSci
Journal of allergy and clinical immunology, 2016, Vol.138 (1), p.16-27
